Shaanxi Panlong Pharmaceutical Stock Forum

Investors are paying premium for the stock despite its limited growth. However, maintaining these prices may be challenging as recent earnings trends could depress the shares. The company's three-year earnings trends aren't affecting its P/E as much as anticipated, considering they look worse than current market expectations.